## Abstract We have examined serial sera from 17 juvenile patients with nasopharyngeal carcinoma (NPC) for their capacity to neutralize the activity of Epstein‐Barr virus (EBV)‐specific DNase. The results revealed that NPC patients who became long‐term survivors (LTS) without evidence of the diseas
Antibody response to Epstein-Barr-virus-specific DNase in 13 patients with nasopharyngeal carcinoma in Taiwan: A retrospective study
✍ Scribed by Jen-Yang Chen; Lu-Yu Hwang; Czau-Siung Yang; R. Palmer Beasley; Chia-Siang Chien
- Publisher
- John Wiley and Sons
- Year
- 1985
- Tongue
- English
- Weight
- 402 KB
- Volume
- 16
- Category
- Article
- ISSN
- 0146-6615
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract Immune responses to three Epstein–Barr virus (EBV) lytic proteins, DNase, thymidine kinase (TK), and BMRF‐1 gene products (50/52 kDa diffused early antigen, EA‐D complex) were determined in EBV‐infected control individuals and patients with nasopharyngeal carcinoma (NPC). Immunofluoresc
Epstein-Barr virus (EBV)-associated nasopharyngeal carcinoma (NPC) generally occurs in adults, especially in high-prevalence populations such as the Chinese and Eskimos. In Maghrebian populations, young patients affected with this malignancy represent 25% of the total NPC cases. In adults with NPC,
The Epstein-Barr virus (EBV) open reading frame BHRF1, a homologue of the oncogene bcl-2, was cloned from a patient with nasopharyngeal carcinoma (NPC) and overexpressed in Escherichia coli. The resulting recombinant BHRF1 fusion protein, with an apparent molecular weight of 35 KD, was used as antig
## Abstract ## BACKGROUND Serologic measurement of antibodies to Epstein–Barr virus (EBV) immunoglobulin A/viral capsid antigen (IgA/VCA) and early antigen (IgA/EA) has been used widely to screen for nasopharyngeal carcinoma (NPC) in China. Recently, it was found that plasma EBV DNA concentration